Authors:
OMIECINSKI CJ
HASSETT C
RAAKA S
LAURENZANA EM
Citation: Cj. Omiecinski et al., HUMAN MICROSOMAL EPOXIDE HYDROLASE - EXPRESSION AND POLYMORPHISM, Naunyn-Schmiedeberg's archives of pharmacology, 358(1), 1998, pp. 51-51
Authors:
HASSETT C
LAURENZANA EM
SIDHU JS
OMIECINSKI CJ
Citation: C. Hassett et al., EFFECTS OF CHEMICAL INDUCERS ON HUMAN MICROSOMAL EPOXIDE HYDROLASE INPRIMARY HEPATOCYTE CULTURES, Biochemical pharmacology, 55(7), 1998, pp. 1059-1069
Citation: Em. Laurenzana et Sm. Owens, METABOLISM OF PHENCYCLIDINE BY HUMAN LIVER-MICROSOMES, Drug metabolism and disposition, 25(5), 1997, pp. 557-563
Citation: Em. Laurenzana et Sm. Owens, BRAIN MICROSOMAL METABOLISM OF PHENCYCLIDINE IN MALE AND FEMALE RATS, Brain research, 756(1-2), 1997, pp. 256-265
Authors:
HASSETT C
LIN J
CARTY CL
LAURENZANA EM
OMIECINSKI CJ
Citation: C. Hassett et al., HUMAN HEPATIC-MICROSOMAL EPOXIDE HYDROLASE - COMPARATIVE-ANALYSIS OF POLYMORPHIC EXPRESSION, Archives of biochemistry and biophysics, 337(2), 1997, pp. 275-283
Citation: Em. Laurenzana et al., ANTIPEPTIDE ANTIBODIES TARGETED AGAINST SPECIFIC REGIONS OF RAT CYP2D1 AND HUMAN CYP2D6, Drug metabolism and disposition, 23(2), 1995, pp. 271-278
Authors:
OWENS SM
GUNNELL M
LAURENZANA EM
VALENTINE JL
Citation: Sm. Owens et al., DOSE-DEPENDENT AND TIME-DEPENDENT CHANGES IN PHENCYCLIDINE METABOLITECOVALENT BINDING IN RATS AND THE POSSIBLE ROLE OF CYP2D1, The Journal of pharmacology and experimental therapeutics, 265(3), 1993, pp. 1261-1266